Compare ATEX & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEX | OMDA |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Nursing Services |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | 2025 |
| Metric | ATEX | OMDA |
|---|---|---|
| Price | $75.24 | $19.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $112.33 | $28.42 |
| AVG Volume (30 Days) | 214.9K | ★ 1.0M |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 891.80 | 94.27 |
| EPS | 0.01 | ★ 0.04 |
| Revenue | $6,501,000.00 | ★ $260,210,000.00 |
| Revenue This Year | $220.44 | $30.17 |
| Revenue Next Year | N/A | $20.40 |
| P/E Ratio | $7,283.53 | ★ $474.75 |
| Revenue Growth | 7.79 | ★ 53.24 |
| 52 Week Low | $17.58 | $10.28 |
| 52 Week High | $113.00 | $26.92 |
| Indicator | ATEX | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 38.69 | 44.20 |
| Support Level | $61.51 | $18.74 |
| Resistance Level | $87.05 | $21.76 |
| Average True Range (ATR) | 5.15 | 1.07 |
| MACD | -0.76 | -0.01 |
| Stochastic Oscillator | 33.02 | 32.96 |
Anterix Inc is the holder of licensed 900 MHz spectrum (896-901/935-940 MHz) with coverage spanning the contiguous United States, Hawaii, Alaska, and Puerto Rico. The Company is focused on commercializing its spectrum assets and delivering intelligent infrastructure solutions, including private broadband networks, tower access, and turnkey connectivity management, to utility and critical infrastructure enterprises. It provides mission-critical private 900 MHz spectrum to the utility sector and integrated deployment solutions that support a secure, resilient, and decarbonized future. Its solutions include 900 MHz Private Wireless, TowerX, and CatalyX.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.